EV Biologics, Inc. (YECO)
OTCMKTS · Delayed Price · Currency is USD
0.0150
-0.0064 (-29.91%)
At close: May 15, 2026
EV Biologics Market Cap
EV Biologics has a market cap or net worth of $153.38 thousand as of May 27, 2026. Its market cap has decreased by -98.14% in one year.
Market Cap
153.38K
Enterprise Value
n/a
Revenue
9.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since June 29, 2015, EV Biologics's market cap has decreased from 70.39M to 153.38K, a decrease of -99.78%. That is a compound annual growth rate of -43.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 153.38K | -81.50% |
| Dec 31, 2025 | 829.28K | -15.08% |
| Dec 31, 2024 | 976.52K | -90.45% |
| Dec 20, 2023 | 10.23M | -56.18% |
| Dec 28, 2022 | 23.33M | 109.88% |
| Dec 31, 2021 | 11.12M | -83.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sorrento Therapeutics | 271.86K |
| Ampio Pharmaceuticals | 207.88K |
| Regen BioPharma | 179.19K |
| GB Sciences | 158.82K |
| Innovation Pharmaceuticals | 158.63K |
| Immunotech Laboratories | 114.99K |
| Synairgen | 110.27K |
| Sigyn Therapeutics | 99.18K |